THIS MONTH
Increasing diagnosis accuracy
A project to reduce the number of inaccurate X-ray diagnoses is being undertaken at the University of Cumbria (Carlisle, UK). Research shows that 20% of X-ray diagnoses are subject to a degree of error. David Manning, Professor of Medical Imaging at the University, estimates that this could be reduced by 25%. In certain examinations, radiographers and radiologist utilise Computer Aided Diagnosis (CAD) software to perform initial scans of an X-ray and highlight any areas of concern. Based on these results observers then study the X-ray visually and make a final diagnosis. The project will consider whether this is the most efficient technique and investigate improving the current system with the help of eye tracking technology. This can analyse the strategies used by experienced radiologists and radiographers and pinpoint which part of the X-ray the eye is focused on and measure it to the accuracy of half of one degree.This information could then be used to reprogramme CAD software to identify disease more efficiently. www.cumbria.ac.uk
Artificial skin sales to soar
The market for bioengineered skin substitutes is forecast to generate total revenues of US$ 475 million by 2010. Several factors have slowed the acceptance of these products until now. One is the lack of cost-effectiveness data, which is the main reason why there is a reluctance to reimburse treatment with tissue repair products. But investment from larger players and ongoing academic programmes have kept the science moving forward, says Applied Data Research in its report. Clinical data from a handful of approved products has demonstrated the potential of skin substitutes, particularly for the treatment of diabetic ulcers and severe burns. Its report also states that demand for bioengineered skin substitutes will be driven by increases in disease prevalence in conditions such as diabetes. Other factors that will increase use include adverse consequences of health care, for example, drug-resistant infections and inappropriate or sub-optimal interventions. www.applieddata.org/cellularmatrices.htm
New Big Apple market place
New York City (New York, USA) could become the centre of commerce and innovation for the US$ 260 billion global medical device and diagnostics market. World Product Centre LLC is to construct a specially designed building that will bring together under one roof the world’s leading manufacturers of medical devices, diagnostics, equipment and supporting systems. The company has announced an agreement under which it will begin to offer medical device manufacturers worldwide licensing and lease agreements in this new, million-square-foot permanent exhibition and conference complex. The building will be constructed in midtown, at 11th Avenue and West 34th Street. The World Product Centre is intended to be an environment that helps doctors, hospital administrators and purchasing agents source, select and integrate the latest advances in medical technology into their health care facilities. Construction is to start at the beginning of 2009 and be completed by 2012. E-mail: callen@rubenstein.com
